New combo therapy aims to keep ovarian cancer at bay longer
Disease control
Recruiting now
This Phase 3 trial is testing whether adding bevacizumab to niraparib after standard chemotherapy helps women with newly diagnosed advanced ovarian cancer stay cancer-free longer. About 970 participants will receive either niraparib alone or niraparib plus bevacizumab as maintena…
Phase: PHASE3 • Sponsor: AGO Study Group • Aim: Disease control
Last updated Jun 26, 2026 15:26 UTC